Related Experiment Video
Updated: Dec 11, 2025
04:30
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
26.1K
In patients with coronary disease and CKD, adding an invasive strategy to MT did not improve outcomes
William G Herrington1, Natalie Staplin1
1MRC Population Health Research Unit at the University of Oxford, Oxford, UK (W.G.H., N.S.).
Annals of Internal Medicine
|August 18, 2020
Insights
This study focuses on managing coronary heart disease in patients with advanced kidney disease. It provides insights into optimal treatment strategies for this complex patient population.
Area of Science:
- Cardiology
- Nephrology
- Clinical Medicine
Background:
- Patients with advanced kidney disease (AKD) often have co-existing coronary heart disease (CHD).
- Managing CHD in AKD presents unique challenges due to altered drug metabolism and increased cardiovascular risk.
- Current guidelines offer limited specific recommendations for this population.
Purpose of the Study:
- To review and synthesize current evidence on the management of coronary heart disease in patients with advanced kidney disease.
- To provide guidance on diagnostic and therapeutic strategies tailored to this high-risk group.
- To highlight areas of uncertainty and future research needs.
Main Methods:
- Comprehensive literature search of major medical databases.
- Review of clinical trials, observational studies, and expert consensus reports.
- Synthesis of findings focusing on risk stratification, medical therapy, and revascularization.
Main Results:
- Patients with AKD and CHD have a significantly higher risk of adverse cardiovascular events.
- The benefits and risks of certain antiplatelet and statin therapies may differ in AKD.
- Revascularization decisions require careful consideration of procedural risks and potential benefits.
Conclusions:
- A multidisciplinary approach involving cardiologists and nephrologists is crucial.
- Individualized treatment plans are necessary, balancing cardiovascular benefits against risks specific to AKD.
- Further research is needed to optimize CHD management in patients with advanced kidney disease.
Abstract
Source Citation:
Bangalore S, Maron DJ, O'Brien SM, et al. Management of coronary disease in patients with advanced kidney disease. N Engl J Med. 2020;382:1608-18. 32227756.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
759
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
759
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
184
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
184
01:22Heart Failure Drugs: Diuretics
692
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
692
01:30Heart Failure V: Medical Management
130
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
130
01:28Chronic Kidney Disease III: Interprofessional Care
245
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
245
01:18Chronic Kidney Disease IV: Nursing Management
197
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
197